These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3160918)

  • 1. Prenatal cytogenetic diagnosis: medical and social implications. Indications, acceptance by doctors and patients, impact and cost: a 10-year review.
    Bell JA; Pearn JH
    Med J Aust; 1985 Jul; 143(2):76-9. PubMed ID: 3160918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal cytogenetic diagnosis--a current audit. A review of 2000 cases of prenatal cytogenetic diagnoses after amniocentesis, and comparisons with early experience.
    Bell JA; Pearn JH; Wilson BH; Ansford AJ
    Med J Aust; 1987 Jan; 146(1):12-5. PubMed ID: 3796389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics, amniocentesis, and abortion.
    Hirschhorn K
    Mt Sinai J Med; 1984; 51(1):15-7. PubMed ID: 6608672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socioeconomic and state-level differences in prenatal diagnosis and live birth prevalence of Down's syndrome in the United States.
    Khoshnood B; Pryde P; Blondel B; Lee KS
    Rev Epidemiol Sante Publique; 2003 Dec; 51(6):617-27. PubMed ID: 14967994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cost-benefit analysis of amniocentesis in the prenatal diagnosis of chromosome abnormalities].
    Moatti JP; Le Gales C; Julian C; Lanoe JL; Ayme S
    Rev Epidemiol Sante Publique; 1990; 38(4):309-21. PubMed ID: 2126880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cost-benefit analysis of prenatal screening for trisomy 21 through analysis of HCG in maternal blood].
    Seror V; Moatti JP; Muller F; Le Galès C; Boué A
    Rev Epidemiol Sante Publique; 1993; 41(1):3-15. PubMed ID: 8465062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A 5-year review of prenatal diagnosis in Graz (author's transl)].
    Zierler H; Rosenkranz W; Winter R; Becker H
    Wien Klin Wochenschr; 1981 Feb; 93(3):75-80. PubMed ID: 6454304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chromosome abnormalities: known risk factors].
    Ayme S; Mattei JF; Mattei MG; Giraud F
    J Genet Hum; 1980 Sep; 28(3):155-78. PubMed ID: 6450823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A conceptual explanation of risk-reduction behavior and intervention development.
    Cox CL; Sullivan JA; Roghmann KJ
    Nurs Res; 1984; 33(3):168-73. PubMed ID: 6563535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT
    CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Investigation of the incidence of aberration in various indication for prenatal cytogenetic analysis].
    Matsuo T; Hisanaga S; Maeda H; Tukimori K; Matsuo K; Nagata H; Nakano H
    Fukuoka Igaku Zasshi; 1992 Oct; 83(10):377-82. PubMed ID: 1464405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of prenatal diagnosis intervention for Down's syndrome in China.
    Chen Y; Qian X; Li J; Zhang J; Chu A; Schweitzer SO
    Int J Technol Assess Health Care; 2007; 23(1):138-45. PubMed ID: 17234028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rates of chromosome abnormalities at different maternal ages.
    Hook EB
    Obstet Gynecol; 1981 Sep; 58(3):282-5. PubMed ID: 6455611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal diagnosis of cytogenetic abnormalities.
    Simpson JL
    Semin Perinatol; 1980 Jul; 4(3):165-78. PubMed ID: 6447915
    [No Abstract]   [Full Text] [Related]  

  • 15. A cost-benefit analysis of prenatal detection of Down syndrome and neural tube defects in older mothers.
    Sadovnick AD; Baird PA
    Am J Med Genet; 1981; 10(4):367-78. PubMed ID: 6460445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health behaviour modelling for prenatal diagnosis in Australia: a geodemographic framework for health service utilisation and policy development.
    Muggli EE; McCloskey D; Halliday JL
    BMC Health Serv Res; 2006 Sep; 6():109. PubMed ID: 16945156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prenatal cytogenetic diagnosis in the 2d trimester in older pregnant women].
    Subrt I; Benesová O; Stirská K; Zwinger A
    Cesk Gynekol; 1989 Nov; 54(9):677-80. PubMed ID: 2533885
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal diagnosis. Results of cytogenetic analysis of amniotic fluid cell cultures.
    Mulcahy MT; Jenkyn J
    Med J Aust; 1973 May; 1(20):979-82. PubMed ID: 4268556
    [No Abstract]   [Full Text] [Related]  

  • 20. Massachusetts Department of Public Health. Use of prenatal cytogenetic diagnosis in New York State.
    Hook EB; Schreinemachers DM; Cross PK
    N Engl J Med; 1981 Dec; 305(23):1410-3. PubMed ID: 7300859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.